These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 15103544

  • 21. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.
    Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY.
    Curr Med Res Opin; 2006 Oct; 22(10):1929-37. PubMed ID: 17022852
    [Abstract] [Full Text] [Related]

  • 22. Managing a fateful alliance: anaemia and cardiovascular outcomes.
    Eckardt KU.
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi16-20. PubMed ID: 15958821
    [Abstract] [Full Text] [Related]

  • 23. [Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure].
    Nikolaev AIu, Ermolenko VM, Milovanova LIu, Milovanov IuS.
    Ter Arkh; 2004 Jun; 76(9):40-3. PubMed ID: 15532375
    [Abstract] [Full Text] [Related]

  • 24. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
    Abaterusso C, Pertica N, Lupo A, Ortalda V, Gambaro G.
    Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
    [Abstract] [Full Text] [Related]

  • 25. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
    Jones M, Schenkel B, Just J.
    Int J Cardiol; 2005 Apr 20; 100(2):253-65. PubMed ID: 15823633
    [Abstract] [Full Text] [Related]

  • 26. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct 20; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 27. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF.
    Lung Cancer; 2004 Nov 20; 46(2):149-56. PubMed ID: 15474662
    [Abstract] [Full Text] [Related]

  • 28. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ, Robinson M, Slevin N, Morgan D, Harrington K, Gaffney C.
    J Clin Oncol; 2009 Dec 01; 27(34):5751-6. PubMed ID: 19884550
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dose tailoring strategies in haemodialysis patients: a discussion of case histories.
    Kleophas W.
    Nephrol Dial Transplant; 2005 Jun 01; 20 Suppl 6():vi31-6. PubMed ID: 15958825
    [Abstract] [Full Text] [Related]

  • 31. Epoetin delta in the management of renal anaemia: results of a 6-month study.
    Martin KJ, Epoetin Delta 3001 Study Group.
    Nephrol Dial Transplant; 2007 Oct 01; 22(10):3052-4. PubMed ID: 17660186
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Oct 01; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 35. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O, Mancuso A, Di Molfetta M, Diana F, Beccaglia P, Cortesi E, De Marinis F.
    Lung Cancer; 2004 Oct 01; 46(1):119-24. PubMed ID: 15364140
    [Abstract] [Full Text] [Related]

  • 36. Anaemia, diabetes and chronic kidney disease: where are we now?
    Stevens PE.
    J Ren Care; 2012 Feb 01; 38 Suppl 1():67-77. PubMed ID: 22348366
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.
    Villar E, Lièvre M, Kessler M, Lemaître V, Alamartine E, Rodier M, François M, Zaoui P, Moranne O, Choukroun G, Guerraoui A, Jolivot A, Janin G, Branger B, Heng AE, Boudray C, Bissery A, Rabilloud M, Pouteil-Noble C.
    J Diabetes Complications; 2011 Feb 01; 25(4):237-43. PubMed ID: 21601481
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.